{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:13:37Z","timestamp":1793830417973,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Liaoning Provincial Science and Technology Program Joint Plan Project","award":["2024-MSLH-547"],"award-info":[{"award-number":["2024-MSLH-547"]}]},{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","award":["XLYC2412076"],"award-info":[{"award-number":["XLYC2412076"]}],"id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic science project of the educational department of Liaoning province","award":["LJ232410159018"],"award-info":[{"award-number":["LJ232410159018"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272043"],"award-info":[{"award-number":["82272043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20758"],"award-info":[{"award-number":["U24A20758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402333"],"award-info":[{"award-number":["82402333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00259-025-07650-z","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T03:42:16Z","timestamp":1765942936000},"page":"3686-3698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Head-to-head comparison of 18F-FAP-2286 PET\/CT and 18F-FDG PET\/CT in the diagnosis and staging of clear cell renal cell carcinoma: a prospective study"],"prefix":"10.1007","volume":"53","author":[{"given":"Yan","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1109-0980","authenticated-orcid":false,"given":"Xuena","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"7650_CR1","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.juro.2009.12.035","volume":"183","author":"BC Leibovich","year":"2010","unstructured":"Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol. 2010;183:1309\u201315. https:\/\/doi.org\/10.1016\/j.juro.2009.12.035.","journal-title":"J Urol"},{"key":"7650_CR2","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/s1470-2045(23)00449-7","volume":"24","author":"MO Grimm","year":"2023","unstructured":"Grimm MO, Esteban E, Barth\u00e9l\u00e9my P, Schmidinger M, Busch J, Valderrama BP, et al. Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2023;24:1252\u201365. https:\/\/doi.org\/10.1016\/s1470-2045(23)00449-7.","journal-title":"Lancet Oncol"},{"key":"7650_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/ju.0000000000001911","volume":"206","author":"SC Campbell","year":"2021","unstructured":"Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal mass and localized renal cancer: Evaluation, Management, and Follow-Up: AUA guideline: part I. J Urol. 2021;206:199\u2013208. https:\/\/doi.org\/10.1097\/ju.0000000000001911.","journal-title":"J Urol"},{"key":"7650_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","volume":"20","author":"RJ Motzer","year":"2022","unstructured":"Motzer RJ, Jonasch E, Agarwal N, Alva A, Baine M, Beckermann K, et al. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20:71\u201390. https:\/\/doi.org\/10.6004\/jnccn.2022.0001.","journal-title":"J Natl Compr Canc Netw"},{"key":"7650_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262.","journal-title":"CA Cancer J Clin"},{"key":"7650_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/ijms24010643","volume":"24","author":"J Rysz","year":"2022","unstructured":"Rysz J, Konecki T, Franczyk B, \u0141awi\u0144ski J, Gluba-Brz\u00f3zka A. The role of long noncoding RNA (lncRNAs) biomarkers in renal cell carcinoma. Int J Mol Sci. 2022;24:643. https:\/\/doi.org\/10.3390\/ijms24010643.","journal-title":"Int J Mol Sci"},{"key":"7650_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","volume":"17","author":"E Jonasch","year":"2021","unstructured":"Jonasch E, Walker CL, Rathmell WK. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol. 2021;17:245\u201361. https:\/\/doi.org\/10.1038\/s41581-020-00359-2.","journal-title":"Nat Rev Nephrol"},{"key":"7650_CR8","doi-asserted-by":"publisher","first-page":"1582887","DOI":"10.3389\/fimmu.2025.1582887","volume":"16","author":"B Wang","year":"2025","unstructured":"Wang B, Xiang Y, Liu X, Pan X, Peng L, Ma J. Advances in immunotherapy and targeted therapy for advanced clear-cell renal cell carcinoma: current strategies and future directions. Front Immunol. 2025;16:1582887. https:\/\/doi.org\/10.3389\/fimmu.2025.1582887.","journal-title":"Front Immunol"},{"key":"7650_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fonc.2016.00201","volume":"6","author":"Y Liu","year":"2016","unstructured":"Liu Y. The place of FDG PET\/CT in renal cell carcinoma: value and limitations. Front Oncol. 2016;6:201. https:\/\/doi.org\/10.3389\/fonc.2016.00201.","journal-title":"Front Oncol"},{"key":"7650_CR10","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1097\/rlu.0000000000005348","volume":"49","author":"M Kiani","year":"2024","unstructured":"Kiani M, Jokar S, Hassanzadeh L, Behnammanesh H, Bavi O, Beiki D, et al. Recent clinical implications of FAPI: imaging and therapy. Clin Nucl Med. 2024;49:e538\u201356. https:\/\/doi.org\/10.1097\/rlu.0000000000005348.","journal-title":"Clin Nucl Med"},{"key":"7650_CR11","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.3390\/biomedicines12091964","volume":"12","author":"K Naito","year":"2024","unstructured":"Naito K, Sangai T, Yamashita K. Caf-associated genes in breast cancer for novel therapeutic strategies. Biomedicines. 2024;12:1964. https:\/\/doi.org\/10.3390\/biomedicines12091964.","journal-title":"Biomedicines"},{"key":"7650_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/ppo.0000000000000719","volume":"30","author":"M Nakayama","year":"2024","unstructured":"Nakayama M, Hope TA, Salavati A. Diagnostic and therapeutic application of fibroblast activation protein inhibitors in oncologic and nononcologic diseases. Cancer J. 2024;30:210\u20137. https:\/\/doi.org\/10.1097\/ppo.0000000000000719.","journal-title":"Cancer J"},{"key":"7650_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1148\/radiol.2020203275","volume":"298","author":"Y Pang","year":"2021","unstructured":"Pang Y, Zhao L, Luo Z, Hao B, Wu H, Lin Q, et al. Comparison of (68)Ga-FAPI and (18)F-FDG uptake in gastric, duodenal, and colorectal cancers. Radiology. 2021;298:393\u2013402. https:\/\/doi.org\/10.1148\/radiol.2020203275.","journal-title":"Radiology"},{"key":"7650_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1148\/radiol.211424","volume":"303","author":"L Wang","year":"2022","unstructured":"Wang L, Tang G, Hu K, Liu X, Zhou W, Li H, et al. Comparison of (68)Ga-FAPI and (18)F-FDG PET\/CT in the evaluation of advanced lung cancer. Radiology. 2022;303:191\u20139. https:\/\/doi.org\/10.1148\/radiol.211424.","journal-title":"Radiology"},{"key":"7650_CR15","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","volume":"49","author":"D Zboralski","year":"2022","unstructured":"Zboralski D, Hoehne A, Bredenbeck A, Schumann A, Nguyen M, Schneider E, et al. Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy. Eur J Nucl Med Mol Imaging. 2022;49:3651\u201367. https:\/\/doi.org\/10.1007\/s00259-022-05842-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7650_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40291-024-00735-9","volume":"28","author":"N Ortolan","year":"2024","unstructured":"Ortolan N, Urso L, Zamberlan I, Filippi L, Buffi NM, Cittanti C, et al. Is there a role for FAPI PET in urological cancers? Mol Diagn Ther. 2024;28:721\u20135. https:\/\/doi.org\/10.1007\/s40291-024-00735-9.","journal-title":"Mol Diagn Ther"},{"key":"7650_CR17","doi-asserted-by":"publisher","unstructured":"Ma Y, Liu G, Du B, Li X, Li Y, Li X. Fibroblast activation Protein-Targeted PET\/CT using [18 F]FAP-2286 for the evaluation of lung cancer: A comparative study with [18 F]FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07495-6.","DOI":"10.1007\/s00259-025-07495-6"},{"key":"7650_CR18","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s00259-023-06461-4","volume":"51","author":"C Civan","year":"2024","unstructured":"Civan C, Kuyumcu S, Has Simsek D, Sanli O, Isik EG, Ozkan ZG, et al. The role of [(68) Ga]Ga-FAPI-04 PET\/CT in renal cell carcinoma: a preliminary study. Eur J Nucl Med Mol Imaging. 2024;51:852\u201361. https:\/\/doi.org\/10.1007\/s00259-023-06461-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7650_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1442-2042.2002.00416.x","volume":"9","author":"H Miyakita","year":"2002","unstructured":"Miyakita H, Tokunaga M, Onda H, Usui Y, Kinoshita H, Kawamura N, et al. Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol. 2002;9:15\u20138. https:\/\/doi.org\/10.1046\/j.1442-2042.2002.00416.x.","journal-title":"Int J Urol"},{"key":"7650_CR20","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/rlu.0000000000000875","volume":"40","author":"M Takahashi","year":"2015","unstructured":"Takahashi M, Kume H, Koyama K, Nakagawa T, Fujimura T, Morikawa T, et al. Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET\/CT. Clin Nucl Med. 2015;40:936\u201340. https:\/\/doi.org\/10.1097\/rlu.0000000000000875.","journal-title":"Clin Nucl Med"},{"key":"7650_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.122.264544","volume":"64","author":"Y Pang","year":"2023","unstructured":"Pang Y, Zhao L, Meng T, Xu W, Lin Q, Wu H, et al. PET imaging of fibroblast activation protein in various types of cancer using (68)Ga-FAP-2286: comparison with (18)F-FDG and (68)Ga-FAPI-46 in a single-center, prospective study. J Nucl Med. 2023;64:386\u201394. https:\/\/doi.org\/10.2967\/jnumed.122.264544.","journal-title":"J Nucl Med"},{"key":"7650_CR22","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1097\/rlu.0000000000004073","volume":"47","author":"TF \u00c7ermik","year":"2022","unstructured":"\u00c7ermik TF, Erg\u00fcl N, Y\u0131lmaz B, Mercano\u011flu G. Tumor imaging with 68Ga-DOTA-FAPI-04 PET\/CT: comparison with 18F-FDG PET\/CT in 22 different cancer types. Clin Nucl Med. 2022;47:e333\u20139. https:\/\/doi.org\/10.1097\/rlu.0000000000004073.","journal-title":"Clin Nucl Med"},{"key":"7650_CR23","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/s12149-021-01673-w","volume":"35","author":"S Zheng","year":"2021","unstructured":"Zheng S, Lin R, Chen S, Zheng J, Lin Z, Zhang Y, et al. Characterization of the benign lesions with increased (68)Ga-FAPI-04 uptake in PET\/CT. Ann Nucl Med. 2021;35:1312\u201320. https:\/\/doi.org\/10.1007\/s12149-021-01673-w.","journal-title":"Ann Nucl Med"},{"key":"7650_CR24","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/bjr\/tqae025","volume":"97","author":"C Guo","year":"2024","unstructured":"Guo C, Liu Y, Yang H, Xia Y, Li X, Chen L, et al. A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET\/CT in renal cell carcinoma. Br J Radiol. 2024;97:859\u201367. https:\/\/doi.org\/10.1093\/bjr\/tqae025.","journal-title":"Br J Radiol"},{"key":"7650_CR25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","volume":"87","author":"A Bex","year":"2025","unstructured":"Bex A, Ghanem YA, Albiges L, Bonn S, Campi R, Capitanio U, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: the 2025 update. Eur Urol. 2025;87:683\u201396. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.020.","journal-title":"Eur Urol"},{"key":"7650_CR26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41598-021-04541-9","volume":"12","author":"AH Zhu","year":"2022","unstructured":"Zhu AH, Hou XY, Tian S, Zhang WF. Diagnostic value of (18)F-FDG PET\/CT versus contrast-enhanced MRI for venous tumour thrombus and venous Bland thrombus in renal cell carcinoma. Sci Rep. 2022;12:587. https:\/\/doi.org\/10.1038\/s41598-021-04541-9.","journal-title":"Sci Rep"},{"key":"7650_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/rlu.0000000000004579","volume":"48","author":"X Yao","year":"2023","unstructured":"Yao X, Liu W, Ou X. 68 Ga-FAPI PET\/MRI and 18 F-FDG PET\/CT in a case with extensive portal vein tumor thrombus. Clin Nucl Med. 2023;48:373\u20135. https:\/\/doi.org\/10.1097\/rlu.0000000000004579.","journal-title":"Clin Nucl Med"},{"key":"7650_CR28","doi-asserted-by":"publisher","first-page":"7755","DOI":"10.7150\/thno.51419","volume":"11","author":"LBN Langer","year":"2021","unstructured":"Langer LBN, Hess A, Korkmaz Z, Tillmanns J, Reffert LM, Bankstahl JP, et al. Molecular imaging of fibroblast activation protein after myocardial infarction using the novel radiotracer [(68)Ga]MHLL1. Theranostics. 2021;11:7755\u201366. https:\/\/doi.org\/10.7150\/thno.51419.","journal-title":"Theranostics"},{"key":"7650_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/rlu.0000000000005051","volume":"49","author":"S Wang","year":"2024","unstructured":"Wang S, Cheng Z, Cui Y, Li X, Li Y. 18 F-FAPI-42 PET\/CT findings in a patient with left ventricular mural thrombus. Clin Nucl Med. 2024;49:274\u20135. https:\/\/doi.org\/10.1097\/rlu.0000000000005051.","journal-title":"Clin Nucl Med"},{"key":"7650_CR30","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2967\/jnumed.124.268351","volume":"65","author":"M Hotta","year":"2024","unstructured":"Hotta M, Kim GHJ, Rerkpichaisuth V, Teng PY, Armstrong WR, Carlucci G, et al. Correlation of FAPI PET uptake with immunohistochemistry in explanted lungs from patients with advanced interstitial lung disease. J Nucl Med. 2024;65:1789\u201394. https:\/\/doi.org\/10.2967\/jnumed.124.268351.","journal-title":"J Nucl Med"},{"key":"7650_CR31","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.3390\/jcm12186033","volume":"12","author":"Y Cui","year":"2023","unstructured":"Cui Y, Wang Y, Wang S, Du B, Li X, Li Y. Highlighting fibroblasts activation in fibrosis: the state-of-the-art fibroblast activation protein inhibitor PET imaging in cardiovascular diseases. J Clin Med. 2023;12:6033. https:\/\/doi.org\/10.3390\/jcm12186033.","journal-title":"J Clin Med"},{"key":"7650_CR32","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00259-023-06167-7","volume":"50","author":"L Zhao","year":"2023","unstructured":"Zhao L, Pang Y, Sun L, Lin Q, Chen H. Extranodal Rosai-Dorfman disease involving pulmonary artery detected by (68)Ga-FAPI PET\/CT and fused (68)Ga-FAPI PET\/MRI. Eur J Nucl Med Mol Imaging. 2023;50:2565\u20136. https:\/\/doi.org\/10.1007\/s00259-023-06167-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7650_CR33","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1007\/s00259-024-06626-9","volume":"51","author":"L Liu","year":"2024","unstructured":"Liu L, Zhong J, Zhang Z, Ye X, Wang X, Liu S. Preclinical study and first-in-human imaging of [(18)F]FAP-2286, and comparison with 2-[(18)F]FDG PET\/CT in various cancer patients. Eur J Nucl Med Mol Imaging. 2024;51:2012\u201322. https:\/\/doi.org\/10.1007\/s00259-024-06626-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7650_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2967\/jnumed.120.259192","volume":"63","author":"RP Baum","year":"2022","unstructured":"Baum RP, Schuchardt C, Singh A, Chantadisai M, Robiller FC, Zhang J, et al. Feasibility, biodistribution, and preliminary dosimetry in peptide-targeted radionuclide therapy of diverse adenocarcinomas using (177)Lu-FAP-2286: first-in-humans results. J Nucl Med. 2022;63:415\u201323. https:\/\/doi.org\/10.2967\/jnumed.120.259192.","journal-title":"J Nucl Med"},{"key":"7650_CR35","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1097\/rlu.0000000000005297","volume":"49","author":"Y Xie","year":"2024","unstructured":"Xie Y, Ma J, Tang W, Zhang Y, Zhang C, Chen Y. Efficacy and safety evaluation of 177Lu-FAP-2286 in the treatment of advanced lung cancer. Clin Nucl Med. 2024;49:830\u20137. https:\/\/doi.org\/10.1097\/rlu.0000000000005297.","journal-title":"Clin Nucl Med"},{"key":"7650_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.euf.2018.08.004","volume":"6","author":"L Evangelista","year":"2020","unstructured":"Evangelista L, Basso U, Maruzzo M, Novara G. The role of radiolabeled prostate-specific membrane antigen positron emission tomography\/computed tomography for the evaluation of renal cancer. Eur Urol Focus. 2020;6:146\u201350. https:\/\/doi.org\/10.1016\/j.euf.2018.08.004.","journal-title":"Eur Urol Focus"},{"key":"7650_CR37","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1007\/s00259-023-06248-7","volume":"50","author":"W Zhu","year":"2023","unstructured":"Zhu W, Li X, Zheng G, Bai C, Ji Z, Zhang H, et al. Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2023;50:3116\u201325. https:\/\/doi.org\/10.1007\/s00259-023-06248-7.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07650-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07650-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07650-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:26:15Z","timestamp":1777274775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07650-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["7650"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07650-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and approval was granted by the Ethics Committee of the first affiliated hospital of China Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publish"}},{"value":"The authors have no interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}